 Raghav Productivity Enh LElectrodes & Refractories | Patent granted for ramming mass production process21 Aug 2026Regulatory Product Approval×3 | pending | ₹1,695 | 7,782 Cr | 135.8vs 49.1 | 27.4% | +11.0% |
 Titagarh Rail SystemsRailway Wagons | Vendor approval for 3-Phase Locomotive Traction Motor from Indian Railways19 Aug 2026Regulatory Product Approval | +1.8% — — | ₹845 | 11,378 Cr | 56.0 | 7.4% | +9.6% |
 Strides Pharma SciPharmaceuticals | Strides gets USFDA clearance for Bengaluru plant19 Aug 2026Regulatory Product Approval | +3.0% — — | ₹984 | 9,070 Cr | 13.8vs 28.5 | 16.6% | +8.4% |
 Centum ElectronicsAerospace & Defense | ECMS approval for Rs. 106 crore investment in Transducers and Filters18 Aug 2026Regulatory Product Approval | +0.4% — — | ₹3,445 | 5,078 Cr | — | 18.0% | +17.1% |
 PCBL ChemicalCarbon Black | PCBL gets ECMS approval for Acetylene Black Project worth Rs 329 cr18 Aug 2026Regulatory Product Approval | +2.9% — — | ₹318 | 12,503 Cr | 148.5 | 3.4% | -4.5% |
 Man Industries (I)Iron & Steel Products | Man Industries wins PML approval from QatarEnergy for LSAW pipes14 Aug 2026Regulatory Product Approval | +8.0% — — | ₹718 | 5,384 Cr | 24.5vs 16.9 | 9.8% | +38.8% |
 FDCPharmaceuticals | FDC subsidiary gets UK MHRA approval for Atropine eye drops13 Aug 2026Regulatory Product Approval×3 | +0.3% — — | ₹348 | 5,667 Cr | 21.5vs 28.5 | 14.7% | +23.6% |
 Embassy DevelopmentsResidential Commercial Projects | Embassy Developments Q1 FY27 pre-sales up 338% YoY at about Rs 868 cr11 Aug 2026Regulatory Product Approval×2 | -4.8% -3.1% — | ₹64.89 | 9,020 Cr | — | -5.8% | -70.8% |
 Apollo Micro SystemsAerospace & Defense | MD letter covers Premier Explosives acquisition and new defence wins8 Aug 2026Regulatory Product Approval×3 | -3.5% -4.4% — | ₹382 | 13,645 Cr | 107.3vs 60.3 | 10.4% | +30.2% |
 Astrazeneca Pharma Ind LTPharmaceuticals | AstraZeneca India gets CDSCO nod for Enhertu additional indication8 Aug 2026Regulatory Product Approval×7 | -3.2% -8.5% — | ₹7,400 | 18,500 Cr | 119.4vs 28.5 | 25.0% | +3.5% |
 Guj Nar Val Fer & Chem LCommodity Chemicals | GNFC Gets Positive Rs 61 Crore Impact from Revised Urea Energy Norms1 Aug 2026Regulatory Product Approval | +1.8% +7.8% — | ₹584 | 8,589 Cr | 7.9vs 17.5 | 10.3% | +12.2% |
 Mas Financial ServNon Banking Financial Company (NBFC) | MAS Financial gets UIDAI approval for Aadhaar authentication services31 Jul 2026Regulatory Product Approval | -2.6% -4.5% — | ₹301 | 5,467 Cr | 14.0vs 17.5 | — | +13.0% |
 Alembic PharmaPharmaceuticals | Alembic Pharma gets USFDA nod for Prucalopride Tablets 1mg and 2mg28 Jul 2026Regulatory Product Approval×18 | -0.7% +2.4% — | ₹819 | 16,093 Cr | 24.0vs 28.5 | 11.2% | -3.3% |
 Kpi Green EnergyPower Generation | CEIG approval received for 100 MW solar project for MAHAGENCO in Maharashtra20 Jul 2026Regulatory Product Approval×2 | -0.6% -4.6% -25.0% | ₹313 | 6,185 Cr | 11.8vs 22.3 | 8.8% | +25.5% |
 Natco PharmaPharmaceuticals | Natco gets tentative US FDA nod for Olaparib tablets18 Jul 2026Regulatory Product Approval×3 | +1.7% -0.9% -7.0% | ₹883 | 15,799 Cr | 18.8vs 28.5 | 15.9% | -45.8% |
 Anand Rathi WealthFinancial Products Distributor | AR Wealth subsidiary gets IFSCA in-principle nod for fund management entity at GIFT City16 Jul 2026Regulatory Product Approval×2 | -0.5% -1.3% +4.4% | ₹2,190 | 18,185 Cr | 44.6vs 21.6 | 48.6% | -3.2% |
 Choice InternationalHolding Company | SEBI approves Choice as Sponsor and Investment Manager for Category II AIF11 Jul 2026Regulatory Product Approval | -2.7% -3.0% -3.0% | ₹807 | 17,977 Cr | 65.7vs 12.8 | 13.9% | +11.8% |
 Punjab & Sind BankPublic Sector Bank | Punjab & Sind Bank gets IFSCA licence for GIFT IFSC banking unit8 Jul 2026Regulatory Product Approval×2 | -0.4% +0.1% -4.2% | ₹23.41 | 16,611 Cr | 22.1vs 15.1 | — | — |
 Computer Age MNGT SerDepositories Clearing Houses and Other Intermediaries | CAMS subsidiary gets IFSCA nod for KYC services at GIFT City3 Jul 2026Regulatory Product Approval | -1.3% -4.2% -1.0% | ₹753 | 18,673 Cr | 19.6 | 43.8% | +4.9% |
 Jubilant PharmovaPharmaceuticals | USFDA tentative approval for Pantoprazole oral suspension26 Jun 2026Regulatory Product Approval | +1.2% +0.9% +1.6% | ₹877 | 13,857 Cr | 39.5vs 28.5 | 4.7% | +16.5% |
 Jindal SawIron & Steel Products | Jindal Saw gets API license reinstated for seamless pipes25 Jun 2026Regulatory Product Approval×2 | +0.8% +1.2% -3.1% | ₹293 | 18,731 Cr | 23.1vs 16.9 | 6.8% | +9.4% |
 Concord BiotechPharmaceuticals | Concord Biotech clears Kenya and Uganda regulator inspections at Unit-II25 Jun 2026Regulatory Product Approval×4 | -1.6% -1.5% -1.9% | ₹1,560 | 16,320 Cr | 58.5vs 28.5 | 16.5% | +32.0% |
 Ola Electric Mobility2/3 Wheelers | Ola Electric gets BIS certification for indigenous 46100 LFP cell23 Jun 2026Regulatory Product Approval×2 | +0.7% +4.4% -13.1% | ₹37.75 | 16,652 Cr | — | -37.0% | -61.6% |
 PuravankaraResidential Commercial Projects | Puravankara gets RERA registration for Miami By Purva project in Mumbai19 Jun 2026Regulatory Product Approval×3 | -3.5% -4.1% -2.5% | ₹218 | 5,176 Cr | 14.9vs 22.3 | 3.7% | +133.1% |
 Gravita IndiaIndustrial Minerals | Gravita's Mundra plant gets LME brand accreditation for lead17 Jun 2026Regulatory Product Approval | +3.8% -1.8% +8.5% | ₹1,824 | 13,463 Cr | 35.0vs 18.6 | 17.2% | +13.3% |
 AvenuesaiFinancial Technology (Fintech) | Receipt of In-Principle Approval by Avenues World FZ LLC, Step Down Subsidiary Company from Central Bank of the UAE for a Retail Payment Services - Category III License4 Jun 2026Regulatory Product Approval | -1.4% +2.7% +21.2% | ₹15.25 | 5,326 Cr | 14.8vs 90.9 | 6.2% | +26.7% |
 Jeena Sikho LifecareWellness | Jeena Sikho Lifecare Limited Has Informed the Exchange About Receipt of NABH Accreditation for Bhopal Hospital.3 Jun 2026Regulatory Product Approval | -10.1% -12.8% -19.7% | ₹507 | 6,300 Cr | 26.6 | 52.2% | +13.5% |
 Bliss GVS PharmaPharmaceuticals | Bliss GVS Pharma Limited has informed the Exchange about Intimation of WHO-GMP Compliance of Manufacturing Facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East).2 Jun 2026Regulatory Product Approval | +4.0% +0.2% +15.6% | ₹576 | 6,095 Cr | 51.7vs 28.5 | 15.1% | +5.2% |
 Corona RemediesPharmaceuticals | CORONA Remedies Limited has informed the Exchange regarding a press release dated May 28, 2026, titled "Press Release - Receipt of EU-GMP Certificate".28 May 2026Regulatory Product Approval×2 | +0.5% +5.7% +17.1% | ₹2,147 | 13,132 Cr | 72.9vs 28.5 | 28.5% | -2.2% |
 Shaily Eng PlasticsPlastic Products - Consumer | Submission of Press Release titled "Shaily Engineering Plastics Limited Announces Regulatory Approval & Launch of Customer Combination Product Incorporating its ShailyPen Neo Device Technology"20 May 2026Regulatory Product Approval | +4.3% +19.4% +5.1% | ₹3,323 | 15,269 Cr | 98.5vs 15.6 | 28.3% | -7.7% |
 Aditya Birla Real EstResidential Commercial Projects | Update on Birla Estates Achieves INR 1007 Crores Sales Booking at Birla Taranya, Thane.20 May 2026Regulatory Product Approval | -1.6% -2.2% +3.0% | ₹1,398 | 15,614 Cr | — | -5.6% | -15.6% |
 Caplin Point LabPharmaceuticals | Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Receipt of final approval by our subsidiary, Caplin Steriles Limited, from the USFDA for Foscarnet Sodium Injection.".14 May 2026Regulatory Product Approval×7 | -1.8% +1.0% +17.3% | ₹2,570 | 19,530 Cr | 29.2vs 28.5 | 21.9% | +12.4% |
 Mahindra Lifespace DevltdResidential Commercial Projects | Detailed disclosure attached herewith6 May 2026Regulatory Product Approval×2 | -1.5% -4.7% -0.9% | ₹383 | 8,160 Cr | 19.4vs 22.3 | -1.2% | +3713.3% |
 Allied Blend N Distils LBreweries & Distilleries | Allied Blenders and Distillers Limited has informed the Exchange about LOI- Andhra Pradesh6 May 2026Regulatory Product Approval | +8.5% -3.5% +3.3% | ₹598 | 16,722 Cr | 77.8vs 25.9 | 17.8% | -2.2% |
 Balrampur Chini MillsSugar | Balrampur Chini Mills Limited has informed the Exchange regarding a press release dated May 06, 2026, titled "New Study by Premier Government Institution Advancing Technical Education and Innovation Across the Plastics Value Chain Confirms PLA Microplastics Breaks Down Safely in Indian Soil, Unlike Conventional Plastics".6 May 2026Regulatory Product Approval | -0.9% +1.5% +2.5% | ₹728 | 14,696 Cr | 26.9vs 8.8 | 9.7% | -4.0% |
 Onesource Specl Pharma LPharmaceuticals | Onesource Specialty Pharma Limited has informed the Exchange regarding a press release dated May 04, 2026, titled "OneSource Supports Second Generic Semaglutide Approval in Canada-Enables commercialisation for the first two entrants in the world s second-largest semaglutide market".4 May 2026Regulatory Product Approval×5 | +0.4% +2.3% +4.2% | ₹1,532 | 17,561 Cr | — | -1.4% | +14.0% |
 Time TechnoplastPlastic Products - Industrial | Time Technoplast Limited has informed the Exchange about approval received from the Petroleum and Explosives Safety Organization (PESO) for the design and manufacturing of 250-litre high-pressure Type IV composite hydrogen cylinders for onboard applications.29 Apr 2026Regulatory Product Approval×2 | +2.0% -3.9% -7.1% | ₹188 | 9,255 Cr | 17.3vs 16.7 | 14.0% | +11.0% |
 PC JewellerGems Jewellery And Watches | PC Jeweller Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals28 Apr 2026Regulatory Product Approval | -1.2% -4.5% 0.0% | ₹10.21 | 8,831 Cr | 11.1vs 20.3 | 8.6% | +12.4% |
 Intellect Design ArenaComputers - Software & Consulting | Intellect Design Arena Limited has informed the Exchange regarding a press release dated April 22, 2026, titled "Press Release - Intellect eMACH.ai Payments Receives Nacha Consulting s Highest Rating Across All Four Major US Payment Rails".22 Apr 2026Regulatory Product Approval | +3.4% +8.4% +3.1% | ₹689 | 9,618 Cr | 32.1vs 19.5 | 13.4% | +11.7% |
 Zen TechnologiesAerospace & Defense | Zen Technologies Limited has informed the Exchange regarding a press release dated April 17, 2026, titled "Zen Technologies receives Arms Manufacturing Licence from Government of India for 12.7mm, 23mm, 30mm and 40mm Cannons".17 Apr 2026Regulatory Product Approval | +7.3% +10.7% +2.8% | ₹1,919 | 17,327 Cr | 100.0vs 60.3 | 15.1% | +2.6% |
